Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Confirmatory Study of the Rapid Mood Screener for Bipolar 1 Disorder to Evaluate Capability to Distinguish Between Subjects With Unipolar Major Depressive Disorder and Bipolar 1 in a Real-world Setting

NCT05956483 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05956483
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05956483 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Confirmatory Study of the Rapid Mood Screener for Bipolar 1 Disorder to Evaluate Capability to Distinguish Between Subjects With Unipolar Major Depressive Disorder and Bipolar 1 in a Real-world Setting
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
December 4, 2023
Completion date
August 16, 2024
Enrollment
423 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar i disorder